Department of Social and Preventive Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, Av. Alfredo Balena, 190, sala 706, Belo Horizonte, MG 30130-100, Brazil.
Clin J Am Soc Nephrol. 2010 Apr;5(4):637-44. doi: 10.2215/CJN.04840709. Epub 2010 Feb 18.
The use of dialysis modalities for ESRD varies around the world. There is no consensus in literature regarding the most appropriate choice of dialysis method. The aim of this study was to analyze the initial modality for ESRD in Brazil and evaluate the factors determining patients' allocation to either hemodialysis (HD) or peritoneal dialysis (PD).
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A retrospective cohort study was performed using national administrative registries of all patients financed by the public system who began renal replacement therapy in 2000 in Brazil. Logistic regression analysis was used to investigate factors associated with the probability of receiving HD or PD at the start of treatment. Independent variables tested were age, sex, presence of diabetes, geographic region of residence, and health care supply indicators.
Of 11,563 patients analyzed, 88% started on HD and 12% started on PD. Patients were more likely to be assigned to HD if they were male (odds ratio: 1.44; 95% confidence interval: 1.23 to 1.68) and nondiabetic (odds ratio: 0.71; 95% confidence interval: 0.60 to 0.84). With regard to age, the youngest and the elderly showed lower probability of being in HD. In addition, the state of residence at the start of treatment was very important to explain initial modality allocation.
Our findings suggest that patient allocation in Brazil is not random. The probability of allocation to HD or PD is highly associated with individual attributes and supply variables.
全世界范围内,终末期肾病(ESRD)患者所使用的透析方式有所不同。对于最适宜的透析方式选择,文献中尚未达成共识。本研究旨在分析巴西 ESRD 的初始治疗模式,并评估决定患者接受血液透析(HD)或腹膜透析(PD)治疗的因素。
设计、地点、参与者和测量方法:采用回顾性队列研究,利用巴西公共系统资助的所有于 2000 年开始肾脏替代治疗的患者的国家行政登记处数据。采用 logistic 回归分析调查治疗起始时接受 HD 或 PD 的概率与相关因素的关系。检验的自变量为年龄、性别、是否合并糖尿病、居住的地理位置和卫生保健供应指标。
在分析的 11563 例患者中,88%起始接受 HD 治疗,12%起始接受 PD 治疗。如果患者为男性(优势比:1.44;95%置信区间:1.23 至 1.68)或非糖尿病患者(优势比:0.71;95%置信区间:0.60 至 0.84),则更有可能接受 HD 治疗。对于年龄而言,年龄最小和年龄最大的患者接受 HD 治疗的可能性较低。此外,治疗起始时的居住地对解释初始治疗模式的分配非常重要。
本研究结果表明,巴西的患者分配并非随机。接受 HD 或 PD 的概率与个体特征和供应变量高度相关。